Medication for influenza, marketed by Glaxo Wellcome under the name Relenza.
Related categories 1
MedlinePlus: Zanamivir Inhalation
Fact sheet on this medication (marketed as Relenza), including proper use, contraindications, and side effects.
Official site from GlaxoSmithKline. Includes prescribing and patient information.
Zanamivir (Relenza) - Influenza Treatment
Medinfo's patient information on this new treatment for influenza, including its use, its cost, and its availability in the United Kingdom.
Last update:January 2, 2007 at 16:33:29 UTC